Ken Griffin Neuronetics, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.73 - $2.0 $21,973 - $60,200	30,100 New	30,100 $22,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $536 - $960	200 New	200 $0
Q3 2023 Nov 14, 2023	BUY	$1.29 - $2.22 $258 - $444	200 Added 50.0%	600 $0
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $7,037 - $9,928	-3,400 Reduced 89.47%	400 $0
Q1 2023 May 15, 2023	SELL	$2.81 - $6.71 $7,306 - $17,446	-2,600 Reduced 40.63%	3,800 $11,000
Q4 2022 Feb 14, 2023	BUY	$2.74 - $6.87 $17,536 - $43,968	6,400 New	6,400 $43,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $25.4M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.